Table 2 Time-dependent characteristics in patients with and without VDRA therapy
Characteristic | Follow-up time (months) | Total | VDRA | No VDRA | p-value |
|---|---|---|---|---|---|
Serum calcium (mg/dl) | 6 | 8.8 | 8.8 | 8.8 | 0.34 |
12 | 8.9 | 8.9 | 8.8 | 0.02 | |
18 | 8.9 | 8.9 | 8.8 | 0.26 | |
24 | 9.0 | 9.0 | 9.0 | 0.2 | |
30 | 9.0 | 8.9 | 8.9 | 0.85 | |
36 | 8.9 | 8.9 | 9.0 | 0.11 | |
Serum phosphorus (mg/dl) | 6 | 5.1 | 5.0 | 5.2 | 0.17 |
12 | 5.2 | 5.2 | 5.3 | 0.29 | |
18 | 5.0 | 5.0 | 5.1 | 0.44 | |
24 | 4.9 | 4.9 | 4.9 | 0.93 | |
30 | 4.9 | 4.9 | 4.9 | 0.56 | |
36 | 4.8 | 4.8 | 4.8 | 0.49 | |
PTH (pg/ml) | 6 | 225 | 313 | 157 | <0.01 |
12 | 197 | 245 | 141.3 | <0.01 | |
18 | 201 | 227 | 155 | <0.01 | |
24 | 212 | 240.3 | 155 | <0.01 | |
30 | 247 | 268.3 | 148.5 | <0.01 | |
36 | 254 | 260 | 197.5 | 0.15 | |
Serum albumin (g/dl) | 6 | 3.60 | 3.55 | 3.55 | 0.09 |
12 | 3.70 | 3.70 | 3.60 | 0.03 | |
18 | 3.75 | 3.78 | 3.70 | 0.19 | |
24 | 3.76 | 3.80 | 3.69 | 0.06 | |
30 | 3.74 | 3.76 | 3.73 | 0.51 | |
36 | 3.80 | 3.72 | 3.81 | 0.42 | |
Hemoglobin (g/dl) | 6 | 10.9 | 11.0 | 10.9 | 0.08 |
12 | 11.4 | 11.4 | 11.5 | 0.79 | |
18 | 11.5 | 11.4 | 11.5 | 0.86 | |
24 | 11.3 | 11.2 | 11.5 | 0.05 | |
30 | 11.2 | 11.2 | 11.3 | 0.23 | |
36 | 11.7 | 11.4 | 11.9 | 0.07 |